What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Endocrinology
- Diabetes mellitus
His scientific interests lie mostly in Internal medicine, Endocrinology, Diabetes mellitus, Adiponectin and Insulin.
His Internal medicine research incorporates themes from Tendon and Streptozotocin.
His Endocrinology study combines topics in areas such as Growth factor and Insulin-like growth factor.
His Adiponectin research incorporates elements of Adipose tissue, Prospective cohort study and Leptin.
His study in Insulin is interdisciplinary in nature, drawing from both Blood sampling, Chemotherapy and Somatostatin.
His work carried out in the field of Type 1 diabetes brings together such families of science as Gastroenterology, Type 2 diabetes and Kidney metabolism.
His most cited work include:
- Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). (1544 citations)
- The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth (741 citations)
- Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure (519 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Endocrinology, Diabetes mellitus, Insulin and Adiponectin are his primary areas of study.
His Internal medicine study frequently draws connections between related disciplines such as Cardiology.
Allan Flyvbjerg combines subjects such as Insulin-like growth factor-binding protein and Growth factor with his study of Endocrinology.
As part of his studies on Diabetes mellitus, Allan Flyvbjerg often connects relevant areas like Disease.
The concepts of his Adiponectin study are interwoven with issues in Body mass index, Adipose tissue, Metabolic syndrome and Adipokine.
He interconnects Muscle hypertrophy and Urinary system in the investigation of issues within Kidney.
He most often published in these fields:
- Internal medicine (98.68%)
- Endocrinology (83.86%)
- Diabetes mellitus (31.63%)
What were the highlights of his more recent work (between 2011-2021)?
- Internal medicine (98.68%)
- Endocrinology (83.86%)
- Diabetes mellitus (31.63%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Endocrinology, Diabetes mellitus, Adiponectin and Cardiology.
The study incorporates disciplines such as Type 1 diabetes and Type 2 diabetes in addition to Internal medicine.
His Endocrinology study frequently draws connections between adjacent fields such as Insulin-like growth factor.
His Diabetes mellitus study combines topics from a wide range of disciplines, such as Periodontitis, Disease and Immunology.
Allan Flyvbjerg works mostly in the field of Adiponectin, limiting it down to topics relating to Body mass index and, in certain cases, Obesity.
His work on Coronary artery disease as part of general Cardiology research is frequently linked to Osteoprotegerin, bridging the gap between disciplines.
Between 2011 and 2021, his most popular works were:
- Effect of liraglutide, a glucagon‐like peptide‐1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)—a multicentre, double‐blind, randomised, placebo‐controlled trial (184 citations)
- Effect of liraglutide, a glucagon‐like peptide‐1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)—a multicentre, double‐blind, randomised, placebo‐controlled trial (184 citations)
- Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes (137 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Diabetes mellitus
His main research concerns Internal medicine, Endocrinology, Cardiology, Adiponectin and Diabetes mellitus.
Allan Flyvbjerg combines topics linked to Type 1 diabetes with his work on Internal medicine.
His work deals with themes such as Nephrology, Transplantation and Insulin-like growth factor, which intersect with Endocrinology.
His studies examine the connections between Cardiology and genetics, as well as such issues in C-reactive protein, with regards to Subclinical infection, Atherosclerotic disease, Ischemic heart, Proportional hazards model and Peripheral.
His Adiponectin study incorporates themes from Adipose tissue, Waist and Type 2 diabetes.
His research integrates issues of Disease, Methylglyoxal, Kidney disease and Endothelial dysfunction in his study of Diabetes mellitus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
